A PHASE 1 STUDY OF VAC85135, A NEOANTIGEN VACCINE REGIMEN TARGETING CALRETICULIN AND JAK2 MUTATIONS, IN COMBINATION WITH IPILIMUMAB (IPI) IN PATIENTS (PTS) WITH MYELOPROLIFERATIVE NEOPLASMS (MPNS)

EHA Library, Salman Otoukesh, 4160910

EFFICACY OF LUSPATERCEPT IN TREATING ANEMIA IN SF3B1-POSITIVE MYELOPROLIFERATIVE NEOPLASMS

EHA Library, Minghui Duan, 4160911

FACTORS ASSOCIATED WITH GRAFT FAILURE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOFIBROSIS: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Yuqian Sun, 4160912

INDIRECT TREATMENT COMPARISON OF GECACITINIB VS RUXOLITINIB IN MYELOFIBROSIS

EHA Library, Yi Zhang, 4160914

IMPACT OF THROMBOSIS ON DISEASE PROGRESSION, CANCER AND MORTALITY IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA

EHA Library, Alberto Alvarez-Larrán, 4160915

RELATIONSHIP BETWEEN HEMOGLOBIN AND QUALITY OF LIFE IN NON-TRANSFUSION-DEPENDENT PATIENTS WITH MYELOFIBROSIS TREATED WITH LUSPATERCEPT

EHA Library, Haifa Kathrin Al-Ali, 4160916

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS TREATED WITH PACRITINIB (PAC) WITH PLATELETS ≥50 X109/L AT PAC INITIATION: INTERIM RESULTS FROM THE MY-PAC STUDY

EHA Library, Douglas Tremblay, 4160917

CLINICAL AND MOLECULAR DIAGNOSTIC CHALLENGES IN MYELOPROLIFERATIVE NEOPLASMS WITH LOW JAK2V617F ALLELIC BURDEN.

EHA Library, Erika Morsia, 4160918

THE ECONOMIC BURDEN OF MYELOFIBROSIS TREATED WITH RUXOLITINIB IN FRANCE

EHA Library, Jean-Jacques Kiladjian, 4160919

DISC-0974 (AN ANTI-HEMOJUVELIN ANTIBODY) IN NON-TRANSFUSION-DEPENDENT PATIENTS WITH MYELOFIBROSIS: LABORATORY CORRELATES OF MAJOR ANEMIA RESPONSE

EHA Library, Ayalew Tefferi, 4160920

IMPACT OF INDIVIDUALIZED DOSING PROFILES OF MIDOSTAURIN ON SAFETY, RESPONSE AND SURVIVAL IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS

EHA Library, Johannes Lübke, 4160921

DEEP MOLECULAR RESPONSES WITH LOW-FIXED DOSE OF ROPEGINTERFERON ALFA-2B IN A ROLLOVER COHORT OF THE LOW-PV TRIAL

EHA Library, Tiziano Barbui, 4160922

PROGNOSTIC ASSESSMENT OF PATIENTS WITH MYELOPROLIFERATIVE NEOPLASM-ASSOCIATED MYELOFIBROSIS IN THE RUXOLITINIB TREATMENT ERA

EHA Library, Ningning Liu, 4160923

THE APPLICABILITY OF CLINICAL, CYTOGENETIC, AND MOLECULAR PREDICTORS OF OUTCOME IN PATIENTS WITH MYELOFIBROSIS IN THE ERA OF JAK INHIBITORS

EHA Library, Haifa Kathrin Al-Ali, 4160924

NEUTROPHIL EXTRACELLULAR TRAPS (NETS) IN MYELOPROLIFERATIVE NEOPLASMS (MPNS): IMPACT OF CYTOREDUCTIVE THERAPY

EHA Library, Elena Torre, 4160925

QRISK3 SCORE IDENTIFIES ESSENTIAL THROMBOCYTHAEMIA AND POLYCYTHAEMIA VERA PATIENTS WHO BENEFIT FROM CYTOREDUCTIVE THERAPY

EHA Library, Andrea Duminuco, 4160926

ANEMIA RESPONSE IN PATIENTS WITH MYELOFIBROSIS TREATED WITH LUSPATERCEPT: A REAL-WORLD COHORT STUDY

EHA Library, Jesus D. Gonzalez-Lugo, 4160927

VALIDATION OF VENOUS THROMBOTIC SCORE (VETS) IN A CONSECUTIVE COHORT OF 335 PATIENTS DIAGNOSED WITH PH- MYELOPROLIFERATIVE NEOPLASM

EHA Library, Maria Helena Parrinello, 4160928

AN EXPLORATORY ANALYSIS OF SYMPTOMATIC BENEFIT IN PATIENTS TREATED WITH GECACITINIB: A FOCUS ON THOSE INTOLERANT OR REFRACTORY/RELAPSED TO RUXOLITINIB

EHA Library, Yi Zhang, 4160929

DIFFERENTIAL IMPACTS OF GRAFT-VERSUS-HOST DISEASE ON SURVIVAL IN CHRONIC MYELOMONOCYTIC LEUKEMIA ACCORDING TO TRANSPLANT MODALITIES

EHA Library, Hidehiro Itonaga, 4160930

OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER CHECKPOINT INHIBITORS IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA PATIENTS: A RETROSPECTIVE ANALYSIS OF THE EBMT-LWP (CHECK-AUTO STUDY)

EHA Library, Carmen Martínez, 4160931

THE CHANGE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES OF HODGKIN LYMPHOMA IN NOVEL AGENT ERA.

EHA Library, Yukiko Misaki, 4160932

IMPACT OF AGE, FRAILTY AND COMORBIDITIES IN THE SURVIVAL OF OLDER PATIENTS WITH HODGKIN LYMPHOMA: A RETROSPECTIVE, MULTICENTER STUDY IN SPAIN FROM THE SPANISH LYMPHOMA REGISTRY (RELINF) OF THE SPANISH GROUP OF LYMPHOMA (GELTAMO)

EHA Library, Raul Cordoba, 4160933

REAL-LIFE EVALUATION OF EFFICACY AND TOLERANCE OF A PET-GUIDED DE-ESCALATION FROM BRECADD TO BRAVD IN FIRST-LINE TREATMENT OF ADVANCED-STAGE HODGKIN LYMPHOMA

EHA Library, Maxime Delforge, 4160934

EFFICACY AND SAFETY OF PEMBROLIZUMAB EVERY 6 WEEKS IN RELAPSED/REFRACTORY (R/R) CLASSIC HODGKIN LYMPHOMA (CHL) OR PRIMARY MEDIASTINAL B-CELL LYMPHOMA (PMBCL): UPDATED ANALYSIS FROM KEYNOTE-B68

EHA Library, Wojciech Jurczak, 4160935

AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER ANTI-PD-1 TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY CLASSICAL HODGKIN LYMPHOMA: UPDATED EFFICACY RESULTS AND CHARACTERISTICS OF RELAPSES

EHA Library, Nikita Mochkin, 4160936

METABOLIC TUMOR VOLUME IN OLDER PATIENTS WITH ADVANCED-STAGE CLASSIC HODGKIN LYMPHOMA: RESULTS FROM THE GHSG HD21 TRIAL

EHA Library, Paul J. Bröckelmann, 4160937

OUTCOMES OF ADOLESCENT AND YOUNG ADULT PATIENTS WITH HODGKIN LYMPHOMA (HL): A SINGLE-CENTER EXPERIENCE

EHA Library, Athanasios Liaskas, 4160938

FIRST-IN-HUMAN, OPEN-LABEL, PHASE 1 STUDY OF CD30-DIRECTED ANTIBODY DRUG CONJUGATE, PF-08046044 (35C), IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMAS: DOSE ESCALATION SAFETY AND PRELIMINARY EFFICACY

EHA Library, Christina Poh, 4160939

REAL-WORLD EVIDENCE OF BRENTUXIMAB VEDOTIN (BV) CONSOLIDATION AFTER AUTOLOGOUS TRANSPLANT (ASCT) IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA (RRHL): 2-YEAR FOLLOW-UP OF GATLA RRHL STUDY

EHA Library, Astrid Pavlovsky, 4160940

A SURVIVAL UPDATE ON A PHASE II TRIAL USING CONVENTIONAL CHEMOTHERAPY PLUS NIVOLUMAB IN ADVANCED STAGE HODGKIN DISEASE (HD)

EHA Library, Maher Salamoon, 4160941

THE ROLE OF AUTOLOGOUS STEM-CELL TRANSPLANTATION AND NIVOLUMAB IN RELAPSED AND REFRACTORY CLASSICAL HODGKIN LYMPHOMA

EHA Library, Ekaterina Fastova, 4160942

PROSPECTIVE MULTICENTER STUDY ON THE EFFECTIVENESS AND SAFETY OF PET-ADAPTED TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA USING ABVD AND EACODD-14 CHEMOTHERAPY REGIMENS (HL-RUSSIA-1): PRELIMINARY RESULTS ON EFFECTIVENESS AND PROGRESSION-FREE SURVIVAL

EHA Library, Nikita Shorokhov, 4160943

PD-1-BASED SALVAGE THERAPY FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA: A MULTICENTER REAL-WORLD ANALYSIS

EHA Library, Hishan Tharmaseelan, 4160944

ZR STUDY: A PROSPECTIVE PHASE II CLINICAL TRIAL EVALUATING ZANUBRUTINIB-RITUXIMAB INDUCTION THERAPY WITH OR WITHOUT AUTOLOGOUS STEM CELL TRANSPLANTATION IN TREATMENT-NAÏVE MANTLE CELL LYMPHOMA

EHA Library, Chang-Ju Qu, 4160945

FIXED-DURATION SUBCUTANEOUS MOSUNETUZUMAB DEMONSTRATES CLINICALLY RELEVANT EFFICACY IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA WITH HIGH-RISK FEATURES: PIVOTAL PHASE II STUDY UPDATE

EHA Library, Georg Heß, 4160946

OBINUTUZUMAB SINGLE AGENT FOR THE FIRST LINE TREATMENT OF MARGINAL ZONE LYMPHOMA: RESULTS OF THE PROSPECTIVE MULTICENTER PHASE II OLYMP-1 TRIAL OF THE GERMAN LYMPHOMA ALLIANCE (GLA)

EHA Library, Christian Buske, 4160947

GOLDILOX: FIRST EXPERIENCE OF SAFETY AND ACTIVITY OF TWO DOSING STRATEGIES OF PIRTOBRUTINIB AND GLOFITAMAB FOR MANTLE CELL LYMPHOMA IN PATIENTS PREVIOUSLY TREATED WITH COVALENT BTK INHIBITORS - AN ALLG STUDY

EHA Library, Chan Y. Cheah, 4160948

THE IMPACT OF TIRABRUTINIB, A SECOND-GENARATION BRUTON'S TYROSINE KINASE INHIBITOR, FOR BING-NEEL SYNDROME: A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Naohiro Sekiguchi, 4160949

LONG-TERM SURVIVAL TRENDS IN ADVANCED-STAGE MANTLE CELL LYMPHOMA: A POOLED ANALYSIS OF SIX RANDOMIZED PHASE III TRIALS FROM 1996 TO 2020

EHA Library, Linmiao Jiang, 4160950

TAFASITAMAB PLUS LENALIDOMIDE AND RITUXIMAB IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: A POST HOC ANALYSIS OF OUTCOMES BY POD24 STATUS FROM THE INMIND STUDY

EHA Library, Marek Trneny, 4160951

BIOMARKER ANALYSES OF THE INFLAMMATORY PROFILE AND MRD CLEARANCE IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) MARGINAL ZONE LYMPHOMA (MZL) VERSUS FOLLICULAR LYMPHOMA (FL) TREATED WITH ODRONEXTAMAB

EHA Library, Geoffrey Chong, 4160952

GOLCADOMIDE (GOLCA), A CEREBLON E3 LIGASE MODULATOR (CELMOD™) AGENT ± RITUXIMAB (R), IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (R/R FL): UPDATED PHASE 1/2 STUDY RESULTS

EHA Library, Raul Cordoba, 4160953

BARRIERS FOR TRIAL INCLUSION AND IMPACT ON SURVIVAL FOR MANTLE CELL LYMPHOMA PATIENTS WITHIN AND OUTSIDE OF THE RANDOMIZED PHASE II/III TRIAL ENRICH

EHA Library, Leila Boukharta, 4160954

LONG-TERM FOLLOW-UP OF VENETOCLAX MONOTHERAPY IN PREVIOUSLY TREATED PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Jorge Castillo, 4160955

REAL-WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH TREATMENT-NAIVE MANTLE CELL LYMPHOMA IN THE UK, SWEDEN, AND FRANCE

EHA Library, Morgane Cheminant, 4160956

BEXOBRUTIDEG (NX-5948), A NOVEL BRUTON'S TYROSINE KINASE DEGRADER, SHOWS HIGH CLINICAL ACTIVITY AND TOLERABLE SAFETY IN AN ONGOING PHASE 1A/B STUDY IN PATIENTS WITH WALDENSTRÖM MACROGLOBULINEMIA

EHA Library, Dima El-Sharkawi, 4160957

PROGNOSTIC IMPACT OF POD24 AND MALT-IPI ON OVERALL SURVIVAL IN EXTRANODAL MARGINAL ZONE LYMPHOMA RECEIVING SYSTEMIC CHEMOTHERAPY: ANALYSIS FROM THE THAI LYMPHOMA STUDY GROUP (TLSG)

EHA Library, Kannadit Prayongratana, 4160958

DETERMINING THE PROGNOSTIC SIGNIFICANCE OF THE KI67 PROLIFERATION INDEX IN TREATMENT-NAÏVE FOLLICULAR LYMPHOMA: AN AUSTRALASIAN LYMPHOMA AND RELATED DISEASES REGISTRY (LARDR) STUDY

EHA Library, Eliza Chung, 4160959

MATCHING-ADJUSTED INDIRECT COMPARISON OF EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE VS TAFASITAMAB WITH RITUXIMAB + LENALIDOMIDE IN SECOND-LINE+ FOLLICULAR LYMPHOMA

EHA Library, Julie Vose, 4160960

EFFICACY AND SAFETY OF NEMTABRUTINIB IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF COHORT G OF THE PHASE 2 BELLWAVE-003 STUDY

EHA Library, Wojciech Jurczak, 4160961

CHIDAMIDE IN COMBINATION WITH ANTI-CD20 MONOCLONAL ANTIBODY PLUS CHOP FOR TREATING NEWLY DIAGNOSED B-CELL NON-HODGKIN LYMPHOMA WITH EPIGENETIC MUTATIONS: PRELIMINARY ANALYSIS FROM A PHASE II STUDY

EHA Library, Hongmei Jing, 4160962

ZANUBRUTINIB COMBINED WITH BENDAMUSTINE AND RITUXIMAB IN PREVIOUSLY UNTREATED PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA: A PROSPECTIVE OPEN-LABEL SINGLE-ARM PHASE II CLINICAL STUDY

EHA Library, He Huang, 4160963

LONG-TERM OUTCOMES IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS WHO DISCONTINUE BRUTON'S TYROSINE KINASE INHIBITOR (BTKI) THERAPY

EHA Library, Karan Chohan, 4160964

SPANISH IMCD REGISTRY EPIDEMIOLOGY OF IDIOPATHIC MULTICENTRIC CASTLEMAN DISEASE IN SPAIN (ARCANA) - PREVALENCE COHORT

EHA Library, Jose Tomás Navarro Ferrando, 4160965

PHASE II INVESTIGATOR-INITIATED TRIAL OF EPCORITAMAB-LENALIDOMIDE IN TREATMENT NAÏVE FOLLICULAR LYMPHOMA

EHA Library, Swetha Thiruvengadam, 4160966

RITUXIMAB, LENALIDOMIDE AND ZANUBRUTINIB CHEMO-FREE REGIMEN FOLLOWED BY IMMUNOCHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED MANTLE CELL LYMPHOMA: AN INVESTIGATOR INITIATED, SINGLE ARM, PHASE 2 TRIAL

EHA Library, Xi Chen, 4160967

THE EXPRESSION INTENSITY OF KI-67 WAS ASSOCIATED WITH PROGNISIS IN FOLLICULAR LYMPHOMA GRADE 3A

EHA Library, Wenjuan Yu, 4160968

BALANCING SAFETY AND EFFICACY OF BENDAMUSTINE PLUS ANTI CD20 REGIMENS IN ELDERLY PATIENTS (>70 Y) WITH FOLLICULAR LYMPHOMA: A TERTIARY ACADEMIC CENTER EXPERIENCE

EHA Library, Mattia D'Antiga, 4160969

RISK STRATIFICATION IN ASYMPTOMATIC WALDENSTRÖM MACROGLOBULINEMIA - VALIDATION AND COMPARISON OF THE DFCI AND SPANISH MODELS

EHA Library, Theresia Akhlaghi, 4160970

A PHASE 1 STUDY OF BI-1206, A MONOCLONAL ANTIBODY TO CD32B (FCγRIIB), IN COMBINATION WITH RITUXIMAB AFTER A BI-1206 SAFETY RUN-IN PHASE IN SUBJECTS WITH INDOLENT B-CELL NON-HODGKIN LYMPHOMA

EHA Library, Zengjun Li, 4160971

PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA TREATED WITH EPCORITAMAB WITHIN THE ENTIRE STUDY COHORT AND IN PATIENTS WITH SYMPTOMS AT BASELINE

EHA Library, P. Connor Johnson, 4160972

DETECTION OF RECURRENT GENOMIC ALTERATIONS AND MINIMAL RESIDUAL DISEASE WITH CELL-FREE DNA AND BONE MARROW IN WALDENSTRÖM'S MACROGLOBULINEMIA.

EHA Library, Signy Chow, 4160973

ASSESSING SECONDARY IMMUNODEFICIENCY IN A COHORT OF PATIENTS WITH WALDENSTRÖM MACROGLOBULINAEMIA

EHA Library, Nicole Japzon, 4160974

ULTRA-LOW DOSE RADIOTHERAPY COMBINED WITH ORELABRUTINIB IMPROVES THE COMPLETE RESPONSE RATE OF TREATMENT FOR LOCALIZED OCULAR ADNEXAL EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA

EHA Library, Shaoxin Yang, 4160975

THE RATIONALITY, EFFICACY AND SAFETY OF ORELABRUTINIB PLUS OBINUTUZUMAB (O2) IN SYSTEMIC TREATMENT-NAÏVE MARGINAL ZONE LYMPHOMA: A PROSPECTIVE COHORT STUDY

EHA Library, Jiadai Xu, 4160976

OBINUTUZUMAB COMBINED WITH BENDAMUSTINE IN THE TREATMENT OF MATURE B-CELL LYMPHOMA: AN OPEN-LABEL, MULTICENTER STUDY

EHA Library, Shuhua Yi, 4160977

CAR T-CELL VS BISPECIFIC ANTIBODIES IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS

EHA Library, Hao Yao, 4160978

EFFICACY AND SAFETY OF ORELABRUTINIB IN COMBINATION WITH OBINUTUZUMAB AND LENALIDOMIDE IN PREVIOUSLY UNTREATED MARGINAL ZONE LYMPHOMA: PRELIMINARY RESULTS FROM A PROSPECTIVE, SINGLE-ARM, MULTICENTER, PHASE II STUDY

EHA Library, Wei Wang, 4160979

NATIONWIDE SURVEY OF THE JOURNEY OF PATIENTS LIVING WITH FOLLICULAR LYMPHOMA IN CHINA: REAL-WORLD INSIGHTS AND ANALYSIS

EHA Library, WeiLi Zhao, 4160980

LENALIDOMIDE AND OBINUTUZUMAB FOR TREATMENT OF CHEMORESISTANT RELAPSED FOLLICULAR LYMPHOMA: A SINGLE-CENTER STUDY

EHA Library, Maria Sannikova, 4160981

GLOFITAMAB PLUS GEMCITABINE AND OXALIPLATIN (GLOFIT-GEMOX) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): 2-YEAR FOLLOW-UP OF STARGLO

EHA Library, Gareth Gregory, 4160983

BASELINE INFLAMMATION PREDICTS RESPONSE TO CD3XCD20 BISPECIFIC T CELL ENGAGERS IN RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA

EHA Library, Giulia Magno, 4160984

INITIAL RESULTS FROM LOTIS-7: A PHASE 1B STUDY OF LONCASTUXIMAB TESIRINE PLUS GLOFITAMAB IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Juan Pablo Alderuccio, 4160985

CIRCULATING TUMOUR DNA-DIRECTED INTERVENTION WITH EPCORITAMAB ALONE OR IN COMBINATION WITH LENALIDOMIDE AND RITUXIMAB IS FEASIBLE IN THE EARLY POST-CAR-T POPULATION AT HIGH RISK OF RELAPSE: PRELIMINARY DATA FROM EPLCART

EHA Library, Mark Dowling, 4160986

FRONTLINE BRENTUXIMAB VEDOTIN AND CHP IN PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA WITH

EHA Library, Swaminathan Iyer, 4160987

MULTICENTER REAL-WORLD OUTCOMES OF FRONTLINE POLA-R-CHP IN TREATMENT NAÏVE DLBCL

EHA Library, Swetha Thiruvengadam, 4160988

RELAPSE PATTERNS AND CLINICAL CHARACTERISTICS OF PATIENTS WITH PRIMARY TESTICULAR LYMPHOMA (PTL) OR TESTICULAR INVOLVEMENT IN THE FLYER, UNFOLDER AND RICOVER-60 TRIALS IN AGGRESSIVE B-CELL-LYMPHOMA

EHA Library, Igor Age Kos, 4160989

OPTIMIZING POST-CHIMERIC ANTIGEN RECEPTOR T CELL MONITORING: EVIDENCE ACROSS LISOCABTAGENE MARALEUCEL PIVOTAL CLINICAL TRIALS AND REAL-WORLD EXPERIENCE

EHA Library, Matthew Lunning, 4160990

ORELABRUTINIB, RITUXIMAB COMBINED WITH HIGH-DOSE METHOTREXATE AS INDUCTION THERAPY IN NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Xibin Xiao, 4160991

FINAL ANALYSIS OF A PHASE 1 STUDY OF ZANUBRUTINIB (ZANU) PLUS LENALIDOMIDE (LEN) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL)

EHA Library, Huilai Zhang, 4160992

TIRABRUTINIB FOR THE TREATMENT OF RELAPSED OR REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA: EFFICACY AND SAFETY FROM THE PHASE II PROSPECT STUDY

EHA Library, Christian Grommes, 4160993

AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION COMBINED WITH CAR-T CELL THERAPY SIGNIFICANTLY IMPROVES PROGRESSION-FREE SURVIVAL IN RELAPSED REFRACTORY CENTRAL NERVOUS SYSTEM LYMPHOMA

EHA Library, Liu Rui, 4160994

RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A MULTINATIONAL REAL-LIFE STUDY

EHA Library, Theodoros Vassilakopoulos, 4160995

OUTCOMES WITH CAR-T IN PATIENTS WITH T CELL HISTIOCYTE-RICH LARGE B-CELL LYMPHOMA, UK EXPERIENCE

EHA Library, Dima El-Sharkawi, 4160996

PLASMABLASTIC LYMPHOMA: POPULATION-BASED TREATMENT STRATEGIES AND OUTCOME

EHA Library, Diana Al-Sarayfi, 4160997

ZILOVERTAMAB VEDOTIN PLUS STANDARD OF CARE IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RESULTS FROM THE PHASE 2/3 WAVELINE-003 STUDY

EHA Library, Antonio Pinto, 4160998

18F-FDG PET RADIOMICS SCORE CONSTRUCTION BY AUTOMATIC MACHINE LEARNING FOR TREATMENT RESPONSE PREDICTION IN ELDERLY PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTER STUDY

EHA Library, Jingyan Xu, 4160999

A CAMPUS ALL RETROSPECTIVE MULTICENTER STUDY ON THE OUTCOME OF ADULT LYMPHOBLASTIC LYMPHOMA PATIENTS TREATED IN THE REAL-LIFE ACCORDING TO THE GIMEMA LAL1913 PROTOCOL

EHA Library, Mario Delia, 4161000

SAFETY AND EFFICACY OF AZD0486, A CD19XCD3 T-CELL ENGAGER, IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA

EHA Library, Dok Hyun Yoon, 4161001

REDEFINING MAINTENANCE STRATEGIES IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA: A DUAL-CENTER RETROSPECTIVE COMPARISON OF BTK INHIBITORS AND LENALIDOMIDE

EHA Library, Xiaoli Chang, 4161002

A PHASE I/II STUDY OF ORELABRUTINIB COMBINED WITH ANTI-PROGRAMMED CELL DEATH PROTEIN-1 ANTIBODY AND FOTEMUSTINE FOR PATIENTS WITH NEWLY DIAGNOSED PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)

EHA Library, Wanyue Zhao, 4161003

THREE-YEAR REAL-WORLD MORTALITY ANALYSIS OF CAR-T THERAPIES: TISA-CEL, AXI-CEL, AND LISO-CEL

EHA Library, Vladimir Otasevic, 4161004

GOLCADOMIDE (GOLCA), A CEREBLON E3 LIGASE MODULATOR (CELMOD™) AGENT, ± RITUXIMAB (R) IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): UPDATED PHASE 1/2 STUDY RESULTS

EHA Library, Emmanuel Bachy, 4161005

TREATMENT OUTCOMES IN NEWLY DIAGNOSED DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS WITH HIGH CARDIOVASCULAR RISK AND TREATED WITH NON-ANTHRACYCLINE-CONTAINING REGIMENS

EHA Library, Justin Darrah, 4161006

ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPECTIVE MULTICENTER PHASE II STUDY

EHA Library, Shujuan Wen, 4161007

AZACYTIDINE COMBINED WITH CHOP REGIMEN FOR THE TREATMENT OF NEWLY DIAGNOSED ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA

EHA Library, Wenjuan Yu, 4161008

BRENTUXIMAB VEDOTIN (BV) IN RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMAS (R/R PTCL): A MULTICENTER RETROSPECTIVE STUDY

EHA Library, Ivan Dlouhy, 4161009

FOUR CYCLES OF R-CHOP SHOW THE SAME EFFECTIVITY AS SIX CYCLES IN REAL-WORLD DLBCL PATIENTS WITH LOCALIZED, NON-BULKY DISEASE INDEPENDENTLY OF OTHER UNFAVOURABLE RISK FACTORS

EHA Library, Diana Malarikova, 4161010

MAINTENANCE THERAPY OF GOLIDOCITINIB, A JAK1 SELECTIVE INHIBITOR, IN PATIENTS WITH PERIPHERAL T CELL LYMPHOMAS AFTER FIRST-LINE SYSTEMIC THERAPY: UPDATES OF THE PHASE 2 STUDY (JACKPOT26)

EHA Library, Jie Jin, 4161011